ESMO E-Learning and V-Learning
Watch E-Learning and V-Learning webcasts produced by leading oncology experts and take the CME test.
ESMO continually develops E-Learning and V-Learning modules covering a broad range of topics relevant for practising oncologists including:
- Recent discoveries and their impact on current treatments for diverse tumour types
- Oncology clinical case studies and conundrums
- Guidance on implementation of the latest ESMO clinical practise guidelines and incorporation of recent clinical advancements
- Selected oncology highlights from the past year
E-Learning and V-Learning modules less than 2 years are accompanied by a CME test (ESMO members only) awarding 1 ESMO-MORA category 1 point and 1 ACOE (Accreditation Council of Oncology in EU) CME credit on successful completion. ESMO members have the option to print the certificate immediately or store in the myESMO CME bank.
Modules marked as V-Learning contain video presentations to enhance your learning experience.
Modules cover key topics in medical oncology including: prostate cancer, mesothelioma, melanoma, gastric cancer, renal cell carcinoma, lymphomas, translational research, cancer immunology, and much more.
|Anti-Cancer Agents & Biologic Therapy - Germ Cell Tumours - Supportive Care||Testicular Cancer: Treatment Strategies and Fertility Preservation||Andrea Garolla, Giovanni Rosti|
|Breast Cancer - Cancer Etiology, Epidemiology, Prevention||Chemo-Endocrine Prevention of Breast Cancer||Andrea De Censi|
|Cancer in Adolescents - Cancer in Young Adults||Cancer in Adolescents and Young Adults||Daniel Stark, George Pentheroudakis, Giannis Mountzios|
|Prostate Cancer||Emerging Treatments for Managing mCRPC Patients||Johann de Bono|
|Cancer Immunology and Immunotherapy - Lung and other Thoracic Tumours - Pathology/Molecular Biology||Future Directions in Clinical Research of NSCLC||Sanjay Popat|
|Melanoma and other Skin Tumours - Translational Research||V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma||James Larkin|
|Lung and other Thoracic Tumours - Translational Research||2013 Highlights in NSCLC||Niels Reinmuth, Martin Reck|
|Renal Cell Cancer||First-line Therapy for Renal Cell Carcinoma: Defining New Standards of Care from Phase III Trials||Joaquim Bellmunt|
|Anti-Cancer Agents & Biologic Therapy - Gastric Cancer||What is the Benefit of Drug Therapy in Advanced Gastric Cancer - and Which Drugs Shall we Use?||Florian Lordick|
|Translational Research||PARP Inhibition - basic science and clinical challenge||Thomas Helleday|
|Thyroid Cancer||New Systemic Treatment Options for Radioiodine-refractory Differentiated and Medullary Thyroid Cancers||Patrick Schöffski|
|Cancer in Pregnancy||Cancer Management During Pregnancy||Nicholas Pavlidis, Stergios Boussios, George Pentheroudakis|
|Lymphomas||DLBCL Clinical case - Adherence to the ESMO Clinical Practice Guidelines||Umberto Vitolo|
|Lung and other Thoracic Tumours - Translational Research||V-Learning: Targeting MET with an emphasis on NSCLC||Solange Peters|
|Palliative and Supportive Care||Pathophysiology and Management of Cancer Cachexia||Ioannis Gioulbasanis|